Literature DB >> 16830362

Amplification of chromosome 21q22.3 harboring trefoil factor family genes in liver fluke related cholangiocarcinoma is associated with poor prognosis.

Kanuengnuch Muenphon1, Temduang Limpaiboon, Patcharee Jearanaikoon, Chawalit Pairojkul, Banchob Sripa, Vajarabhongsa Bhudhisawasdi.   

Abstract

AIM: To determine allelic imbalance on chromosomal region 21q22-qter including trefoil factor family genes (TFF) in cholangiocarcinoma (CCA) patients and analyze the correlation between allelic imbalances and clinicopathological parameters.
METHODS: Quantitative PCR amplification was performed on four microsatellite markers and trefoil factor family genes (TFF1, TFF2, and TFF3) using a standard curve and SYBR Green I dye method. The relative copy number was determined by DNA copy number of tested locus to reference locus. The relative copy number was interpreted as deletion or amplification by comparison with normal reference range. Associations between allelic imbalance and clinicopathological parameters of CCA patients were evaluated by chi(2)-tests. Kaplan-Meier method was used to analyze survival.
RESULTS: The frequencies of amplification at D21S1890, D21S1893, and TFF3 were 32.5%, 30.0%, and 28.7%, respectively. Patients who had amplification at regions covering D21S1893, D21S1890, and TFF showed poor prognosis, whereas patients who had deletion showed favorable prognosis (mean: 51.7 wk vs 124.82 wk, P = 0.012). Multivariate Cox regression analysis revealed that amplification of D21S1893, D21S1890 and TFF, blood vessel invasion, and staging were associated with poor prognosis.
CONCLUSION: D21S1893-D21S1890 region may harbor candidate genes especially TFF and serine protease family, which might be involved in tumor invasion and metastasis contributing to poor survival. The amplification in this region may be used as a prognostic marker in the treatment of CCA patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16830362      PMCID: PMC4087361          DOI: 10.3748/wjg.v12.i26.4143

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  34 in total

1.  Differential expression of mucins and trefoil peptides in native epithelium, Barrett's metaplasia and squamous cell carcinoma of the oesophagus.

Authors:  C Labouvie; J C Machado; F Carneiro; M Sarbia; M Vieth; R Porschen; G Seitz; N Blin
Journal:  J Cancer Res Clin Oncol       Date:  1999       Impact factor: 4.553

2.  Expression of human intestinal trefoil factor in malignant cells and its regulation by oestrogen in breast cancer cells.

Authors:  F E May; B R Westley
Journal:  J Pathol       Date:  1997-08       Impact factor: 7.996

3.  Intrahepatic cholangiocarcinoma in Thailand.

Authors:  T Uttaravichien; V Bhudhisawasdi; C Pairojkul; A Pugkhem
Journal:  J Hepatobiliary Pancreat Surg       Date:  1999

4.  Intestinal trefoil factor controls the expression of the adenomatous polyposis coli-catenin and the E-cadherin-catenin complexes in human colon carcinoma cells.

Authors:  J A Efstathiou; M Noda; A Rowan; C Dixon; R Chinery; A Jawhari; T Hattori; N A Wright; W F Bodmer; M Pignatelli
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-17       Impact factor: 11.205

Review 5.  Microstructure and development of the normal and pathologic biliary tract in humans, including blood supply.

Authors:  Y Nakanuma; M Hoso; T Sanzen; M Sasaki
Journal:  Microsc Res Tech       Date:  1997-09-15       Impact factor: 2.769

6.  Phosphorylation of beta-catenin and epidermal growth factor receptor by intestinal trefoil factor.

Authors:  D Liu; I el-Hariry; A J Karayiannakis; J Wilding; R Chinery; W Kmiot; P D McCrea; W J Gullick; M Pignatelli
Journal:  Lab Invest       Date:  1997-12       Impact factor: 5.662

7.  Mapping of a new target region of allelic loss to a 6-cM interval at 21q21 in primary breast cancers.

Authors:  K Ohgaki; A Iida; F Kasumi; G Sakamoto; M Akimoto; Y Nakamura; M Emi
Journal:  Genes Chromosomes Cancer       Date:  1998-11       Impact factor: 5.006

Review 8.  Protease inhibitors: role and potential therapeutic use in human cancer.

Authors:  Y A DeClerck; S Imren
Journal:  Eur J Cancer       Date:  1994       Impact factor: 9.162

9.  Mutations of the p53 tumor suppressor gene and the ras gene family in intrahepatic cholangiocellular carcinomas in Japan and Thailand.

Authors:  T Kiba; H Tsuda; C Pairojkul; S Inoue; T Sugimura; S Hirohashi
Journal:  Mol Carcinog       Date:  1993       Impact factor: 4.784

10.  Enhancement of DHPN induced hepatocellular, cholangiocellular and pancreatic carcinogenesis by Opisthorchis viverrini infestation in Syrian golden hamsters.

Authors:  W Thamavit; M A Moore; Y Hiasa; N Ito
Journal:  Carcinogenesis       Date:  1988-06       Impact factor: 4.944

View more
  10 in total

1.  Effects of thymidine phosphorylase on tumor aggressiveness and 5-fluorouracil sensitivity in cholangiocarcinoma.

Authors:  Jongkonnee Thanasai; Temduang Limpaiboon; Patcharee Jearanaikoon; Banchob Sripa; Chawalit Pairojkul; Srisurang Tantimavanich; Masanao Miwa
Journal:  World J Gastroenterol       Date:  2010-04-07       Impact factor: 5.742

2.  Trefoil factors: tumor progression markers and mitogens via EGFR/MAPK activation in cholangiocarcinoma.

Authors:  Kanuengnuch Kosriwong; Trevelyan R Menheniott; Andrew S Giraud; Patcharee Jearanaikoon; Banchob Sripa; Temduang Limpaiboon
Journal:  World J Gastroenterol       Date:  2011-03-28       Impact factor: 5.742

3.  Trefoil factor-3 expression in human colon cancer liver metastasis.

Authors:  Mark Babyatsky; Jing Lin; Xianyang Yio; Anli Chen; Jie-yu Zhang; Yan Zheng; Christina Twyman; Xiuliang Bao; Myron Schwartz; Swan Thung; J Lawrence Werther; Steven Itzkowitz
Journal:  Clin Exp Metastasis       Date:  2008-11-02       Impact factor: 5.150

4.  DNA index is a strong predictive marker in intrahepatic cholangiocarcinoma: the results of a five-year prospective study.

Authors:  Carsten Kamphues; Nadine Al-Abadi; Angelika Dürr; Roberta Bova; Frederick Klauschen; Albrecht Stenzinger; Marcus Bahra; Hussein Al-Abadi; Peter Neuhaus; Daniel Seehofer
Journal:  Surg Today       Date:  2013-08-24       Impact factor: 2.549

5.  Genomic alterations in breast cancer patients in betel quid and non betel quid chewers.

Authors:  Mishi Kaushal; Ashwani K Mishra; Jagannath Sharma; Eric Zomawia; Amal Kataki; Sujala Kapur; Sunita Saxena
Journal:  PLoS One       Date:  2012-08-24       Impact factor: 3.240

Review 6.  An Omics Perspective on Molecular Biomarkers for Diagnosis, Prognosis, and Therapeutics of Cholangiocarcinoma.

Authors:  Pattaya Seeree; Phorutai Pearngam; Supeecha Kumkate; Tavan Janvilisri
Journal:  Int J Genomics       Date:  2015-09-02       Impact factor: 2.326

7.  Impact of NPM, TFF3 and TACC1 on the prognosis of patients with primary gastric cancer.

Authors:  Aiping Ding; Wenwen Zhao; Xiaoli Shi; Ruyong Yao; Fang Zhou; Lu Yue; Shihai Liu; Wensheng Qiu
Journal:  PLoS One       Date:  2013-12-16       Impact factor: 3.240

8.  Serum TFF1 and TFF3 but not TFF2 are higher in women with breast cancer than in women without breast cancer.

Authors:  Yuko Ishibashi; Hiroshi Ohtsu; Masako Ikemura; Yasuko Kikuchi; Takayoshi Niwa; Kotoe Nishioka; Yoshihiro Uchida; Hirona Miura; Susumu Aikou; Toshiaki Gunji; Nobuyuki Matsuhashi; Yasukazu Ohmoto; Takeshi Sasaki; Yasuyuki Seto; Toshihisa Ogawa; Keiichiro Tada; Sachiyo Nomura
Journal:  Sci Rep       Date:  2017-07-07       Impact factor: 4.379

9.  Clinical Significance of the HHLA2 Protein in Hepatocellular Carcinoma and the Tumor Microenvironment.

Authors:  Min Luo; Yan Lin; Rong Liang; Yongqiang Li; Lianying Ge
Journal:  J Inflamm Res       Date:  2021-08-28

10.  Cloning and characterization of the human trefoil factor 3 gene promoter.

Authors:  Yong Sun; Liangxi Wang; Yifang Zhou; Xuefei Mao; Xiangdong Deng
Journal:  PLoS One       Date:  2014-04-17       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.